ADVERTISEMENT
Posted: Dec 7, 2021

Rethinking statin adverse effects and factoring in the “nocebo” effect

Statins

Results of a September 2021 study by Howard and colleagues published in the Journal of the American College of Cardiology show that, in patients with a history of stopping statin therapy due to intolerable adverse effects, a similar amount of adverse effects were observed whether patients were rechallenged with a statin or were taking a placebo.

Maria G. Tanzi, PharmD

Read more
Posted: Dec 7, 2021

DEA issues safety alert on counterfeit meds

Counterfeit Pills

The DEA is alerting the public to the dangers of counterfeit medications containing the powerful synthetic opioid fentanyl.

Loren Bonner

Read more
Posted: Dec 7, 2021

Should medical cannabis be used to treat chronic pain?

Medical Cannabis

According to CDC, people most often cite pain management as their reason for using medical cannabis in the United States.

Clarissa Chan, PharmD

Read more
Posted: Dec 7, 2021

Pharmacists and hypertension management: Reflecting one year after the Surgeon General’s call to action

Hypertension

A CDC evaluation found that 66% of participants in a pharmacistled hypertension program—the University of Michigan Health Hypertension Pharmacists’ Program—achieved blood pressure control within 3 months of starting the program, compared to only 42% of non-participants.

Olivia Welter, PharmD

Read more
Posted: Dec 7, 2021

Are synbiotic supplements all they claim to be?

On The Shelf

According to a 2021 article published in Gastroenterology by O’Connor and colleagues, approximately 1 in 20 people in the United States are using a prebiotic, probiotic, or synbiotic supplement.

Johanna Taylor Katroscik

Read more
12

Related Articles

Advertisement
Advertisement
Advertisement
Advertisement
ADVERTISEMENT